Proposed Data Collection Submitted for Public Comment and Recommendations, 11993-11995 [2020-04084]
Download as PDF
<![CDATA[
Federal Register / Vol. 85, No. 40 / Friday, February 28, 2020 / Notices
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–04098 Filed 2–27–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Clinical Laboratory Improvement
Advisory Committee (CLIAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Clinical Laboratory Improvement
Advisory Committee (CLIAC). This
meeting is open to the public, limited
only by the space available. The meeting
room accommodates approximately 100
people. The public is also welcome to
view the meeting by webcast. Check the
CLIAC website on the day of the
meeting for the webcast link
www.cdc.gov/cliac.
DATES: The meeting will be held on
April 16, 2020, 8:30 a.m. to 5:00 p.m.,
EDT and April 17, 2020, 8:30 a.m. to
11:30 a.m., EDT.
ADDRESSES: Food and Drug
Administration (FDA), White Oak
Campus, 10903 New Hampshire
Avenue, Building 31, Great Room,
Silver Spring, Maryland 20993 and via
webcast at www.cdc.gov/cliac.
FOR FURTHER INFORMATION CONTACT:
Nancy Anderson, MMSc, MT(ASCP),
Senior Advisor for Clinical Laboratories,
Division of Laboratory Systems, Center
for Surveillance, Epidemiology and
Laboratory Services, Office of Public
Health Scientific Services, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, Mailstop V24–3,
Atlanta, Georgia 30329–4018, telephone
(404) 498–2741; NAnderson@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: This Committee is charged
with providing scientific and technical
advice and guidance to the Secretary of
Health and Human Services (HHS); the
Assistant Secretary for Health; the
Director, Centers for Disease Control
and Prevention; the Commissioner,
Food and Drug Administration (FDA);
and the Administrator, Centers for
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:27 Feb 27, 2020
Jkt 250001
Medicare and Medicaid Services (CMS).
The advice and guidance pertain to
general issues related to improvement in
clinical laboratory quality and
laboratory medicine practice and
specific questions related to possible
revision of the Clinical Laboratory
Improvement Amendment (CLIA)
standards. Examples include providing
guidance on studies designed to
improve safety, effectiveness, efficiency,
timeliness, equity, and patientcenteredness of laboratory services;
revisions to the standards under which
clinical laboratories are regulated; the
impact of proposed revisions to the
standards on medical and laboratory
practice; and the modification of the
standards and provision of nonregulatory guidelines to accommodate
technological advances, such as new
test methods, the electronic
transmission of laboratory information,
and mechanisms to improve the
integration of public health and clinical
laboratory practices.
All people attending the CLIAC
meeting in-person are required to
register for the meeting online at least
five business days in advance for U.S.
citizens and at least 10 business days in
advance for international registrants.
Register at: www.cdc.gov/cliac. Register
by scrolling down and clicking the
‘‘Register for this Meeting’’ button and
completing all forms according to the
instructions given. Please complete all
the required fields before submitting
your registration and submit no later
than April 8, 2020, for U.S. registrants
and April 1, 2020, for international
registrants.
It is the policy of CLIAC to accept
written public comments and provide a
brief period for oral public comments on
agenda items. Public comment periods
for each agenda item are scheduled
immediately prior to the Committee
discussion period for that item. In
general, each individual or group
requesting to make oral comments will
be limited to a total time of five minutes
(unless otherwise indicated). To assure
adequate time is scheduled for public
comments, speakers should notify the
contact person below at least 5 business
days prior to the meeting date. For
individuals or groups unable to attend
the meeting, CLIAC accepts written
comments until the date of the meeting
(unless otherwise stated). However, it is
requested that comments be submitted
at least 5 business days prior to the
meeting date so that the comments may
be made available to the Committee for
their consideration and public
distribution. Written comments should
be provided to the contact person at the
mailing or email address below, and
PO 00000
Frm 00048
Fmt 4703
Sfmt 4703
11993
will be included in the meeting’s
Summary Report.
The CLIAC meeting materials will be
made available to the Committee and
the public in electronic format (PDF) on
the internet instead of by printed copy.
Check the CLIAC website on the day of
the meeting for materials: www.cdc.gov/
cliac.
Matters to be Considered: The agenda
will include agency updates from CDC,
CMS, and FDA. Presentations and
discussions will focus on an update on
CLIAC recommendations; an update on
the Genetic Testing Reference Materials
Coordination Program (GeT–RM); an
update of the December 2019 CDC’s
Board of Scientific Counselors, Deputy
Director for Infectious Diseases meeting;
a report from the Office of the National
Coordinator for Health Information
Technology (ONC) Health Information
Technology Advisory Committee; the
laboratory response to the COVID–19
coronavirus disease outbreak; and
technological advances in digital
imaging. Agenda items are subject to
change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–04068 Filed 2–27–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–20–0493; Docket No. CDC–2020–
0015]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
SUMMARY:
E:\FR\FM\28FEN1.SGM
28FEN1
11994
Federal Register / Vol. 85, No. 40 / Friday, February 28, 2020 / Notices
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled 2021 and 2023 National Youth
Risk Behavior Surveys (YRBS). CDC is
requesting a three-year approval to
reinstate, with changes, the data
collection for the national YRBS, a
biennially school-based survey of high
school students in the United States.
DATES: CDC must receive written
comments on or before April 28, 2020.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2020–
0015 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments through
the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
FOR FURTHER INFORMATION CONTACT:
OMB approval for the 2017 YRBS and
2019 YRBS expired September 30, 2019
(OMB Control No. 0920–0493). CDC
seeks a three-year approval to conduct
the YRBS in Spring 2021 and Spring
2023. Minor changes incorporated into
this reinstatement request include: An
updated title for the information
collection to accurately reflect the years
in which the survey will be conducted,
minor changes to the data collection
instrument, and the use of a tablet-based
data collection methodology starting in
2023.
The YRBS assesses priority health risk
behaviors related to the major
preventable causes of mortality,
morbidity, and social problems among
both youth and young adults in the
United States. Data on health risk
behaviors of adolescents are the focus of
approximately 65 national health
objectives in Healthy People 2030, an
initiative of the U.S. Department of
Health and Human Services (HHS). The
YRBS provides data to measure 13 of
the proposed health objectives and one
of the Leading Health Indicators
currently under public comment to
establish Healthy People 2030
objectives. In addition, the YRBS can
identify racial and ethnic disparities in
health risk behaviors. No other national
source of data measures as many of the
Healthy People 2030 objectives
addressing adolescent health risk
behaviors as the YRBS. The data also
will have significant implications for
policy and program development for
school health programs nationwide.
In Spring 2021 and Spring 2023, the
YRBS will be conducted among
nationally representative samples of
students attending public and private
schools in grades 9–12. Information
supporting the YRBS also will be
collected from state-, district-, and
school-level administrators and
teachers. The table below reports the
number of respondents annualized over
the three-year project period. There are
no costs to respondents except their
time. The total estimated annualized
burden hours are 6,259.
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
2021 and 2023 National Youth Risk
Behavior Surveys (OMB Contrtol No.
0920–0493)—Reinstatement with
change—National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention
(NCHHSTP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The purpose of this request is to
obtain OMB approval to reinstate with
change, the data collection for the
National Youth Risk Behavior Survey
(YRBS), a school-based survey that has
been conducted biennially since 1991.
jbell on DSKJLSW7X2PROD with NOTICES
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondent
Form name
State Administrators ..............
State-level Recruitment Script for the Youth
Risk Behavior Survey.
District-level Recruitment Script for the
Youth Risk Behavior Survey.
District-level Recruitment Script for the
Youth Risk Behavior Survey.
District Administrators ...........
School Administrators ...........
VerDate Sep<11>2014
18:12 Feb 27, 2020
Jkt 250001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
17
1
30/60
9
80
1
30/60
40
133
1
30/60
67
E:\FR\FM\28FEN1.SGM
28FEN1
11995
Federal Register / Vol. 85, No. 40 / Friday, February 28, 2020 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hours)
Total burden
hours
Type of respondent
Form name
Teachers ...............................
440
1
15/60
110
Students ................................
Data Collection Checklist for the Youth Risk
Behavior Survey.
Youth Risk Behavior Survey ........................
8,045
1
45/60
6,034
Total ...............................
.......................................................................
........................
........................
........................
6,259
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–04084 Filed 2–27–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Personal Responsibility
Education Program (PREP)
Performance Measures and Adulthood
Preparation Subjects (PMAPS)
Studies—Data Collection Related to
the Performance Measures Study—
Extension (OMB #0970–0497).
Office of Planning, Research,
and Evaluation; Administration for
Children and Families; HHS.
ACTION: Request for public comment.
AGENCY:
A goal of the Performance
Measures and Adulthood Preparation
Subjects (PMAPS) studies is to collect,
analyze, and report on performance
measure data for the Personal
Responsibility Education Program
(PREP) programs. The Office of
Planning, Research, and Evaluation
(OPRE) and the Family and Youth
Services Bureau (FYSB) in the
SUMMARY:
Administration for Children and
Families (ACF) request a revision to a
currently approved information
collection (OMB No. 0970–0497;
expiration date: 04/30/2020). The
purpose of the request is to make
adaptions to the participant entry and
exit surveys, and continue the ongoing
data collection of the performance
measures from PREP grantees.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
the Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
ADDRESSES: Copies of the proposed
collection of information can be
obtained and comments may be
forwarded by emailing
OPREinfocollection@acf.hhs.gov.
Alternatively, copies can also be
obtained by writing to the
Administration for Children and
Families, Office of Planning, Research,
and Evaluation, 330 C Street SW,
Washington, DC 20201, Attn: OPRE
Reports Clearance Officer. All requests,
emailed or written, should be identified
by the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: The PMAPS studies
consist of two components: The
Performance Measures Study and the
Adulthood Preparation Subjects Study.
The data collection for the Adulthood
Preparation Subjects Study is complete.
This notice is specific to a request for an
extension of data collection activities for
the Performance Measures Study only.
The Performance Measures Study
component includes collection and
analysis of performance measure data
from State PREP (SPREP), Tribal PREP
(TPREP), Competitive PREP (CPREP),
and Personal Responsibility Education
Innovative Strategies (PREIS) grantees.
Data will be used to determine if PREP
and PREIS grantees are meeting
performance benchmarks related to the
program’s mission and priorities.
This request includes the
development of adapted participant
entry and exit surveys for middle school
students (6th, 7th, and 8th grade youth)
that exclude the most sensitive
questions pertaining to sexual behavior.
This is because some of the PREP
middle school curricula do not include
topics on sexual behavior, i.e., focus
only on healthy relationship education.
The adapted surveys will be used by all
grantees that serve middle school youth.
In addition, some minor edits have been
made to the high school surveys.
Respondents: Performance
measurement data collection
instruments will be administered to
individuals representing SPREP, TPREP,
CPREP, and PREIS grantees, their subawardees, and program participants.
ANNUAL BURDEN ESTIMATES
Total number
of respondents
jbell on DSKJLSW7X2PROD with NOTICES
Instrument
PREP Participant Entry Survey ...........................................
PREP Participant Exit Survey ..............................................
Performance Reporting System Data Form—State grantees ....................................................................................
Performance Reporting System Data Form—TPREP
grantees ............................................................................
Performance Reporting System Data Form—CPREP
grantees ............................................................................
Performance Reporting System Data Form—PREIS grantees ....................................................................................
Performance Reporting System Data Form—State subawardees ..........................................................................
VerDate Sep<11>2014
17:27 Feb 27, 2020
Jkt 250001
PO 00000
Frm 00050
Annual
number of
respondents
Number of
responses per
respondent
Average
burden hours
per response
Annual burden
hours
319,673
291,624
106,558
97,208
1
1
0.15
0.13333
15,984
12,961
153
51
2
18
1,836
28
9
2
18
324
75
25
2
14
700
38
13
2
14
364
987
329
2
14
9,212
Fmt 4703
Sfmt 4703
E:\FR\FM\28FEN1.SGM
28FEN1
]]>Agencies
[Federal Register Volume 85, Number 40 (Friday, February 28, 2020)]
[Notices]
[Pages 11993-11995]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-04084]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-20-0493; Docket No. CDC-2020-0015]
Proposed Data Collection Submitted for Public Comment and
Recommendations
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), as part
of its continuing effort to reduce public burden and maximize the
utility of government information, invites the
[[Page 11994]]
general public and other Federal agencies the opportunity to comment on
a proposed and/or continuing information collection, as required by the
Paperwork Reduction Act of 1995. This notice invites comment on a
proposed information collection project titled 2021 and 2023 National
Youth Risk Behavior Surveys (YRBS). CDC is requesting a three-year
approval to reinstate, with changes, the data collection for the
national YRBS, a biennially school-based survey of high school students
in the United States.
DATES: CDC must receive written comments on or before April 28, 2020.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0015 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Jeffrey M. Zirger, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE, MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. CDC will post, without change, all relevant comments
to Regulations.gov.
Please note: Submit all comments through the Federal
eRulemaking portal (regulations.gov) or by U.S. mail to the address
listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of the information collection plan
and instruments, contact Jeffrey M. Zirger, Information Collection
Review Office, Centers for Disease Control and Prevention, 1600 Clifton
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email:
[email protected].
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide a 60-day notice in the Federal Register
concerning each proposed collection of information, including each new
proposed collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to the OMB for approval. To
comply with this requirement, we are publishing this notice of a
proposed data collection as described below.
The OMB is particularly interested in comments that will help:
1. Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
2. Evaluate the accuracy of the agency's estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and clarity of the information to
be collected; and
4. Minimize the burden of the collection of information on those
who are to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submissions of responses.
5. Assess information collection costs.
Proposed Project
2021 and 2023 National Youth Risk Behavior Surveys (OMB Contrtol
No. 0920-0493)--Reinstatement with change--National Center for HIV/
AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
The purpose of this request is to obtain OMB approval to reinstate
with change, the data collection for the National Youth Risk Behavior
Survey (YRBS), a school-based survey that has been conducted biennially
since 1991. OMB approval for the 2017 YRBS and 2019 YRBS expired
September 30, 2019 (OMB Control No. 0920-0493). CDC seeks a three-year
approval to conduct the YRBS in Spring 2021 and Spring 2023. Minor
changes incorporated into this reinstatement request include: An
updated title for the information collection to accurately reflect the
years in which the survey will be conducted, minor changes to the data
collection instrument, and the use of a tablet-based data collection
methodology starting in 2023.
The YRBS assesses priority health risk behaviors related to the
major preventable causes of mortality, morbidity, and social problems
among both youth and young adults in the United States. Data on health
risk behaviors of adolescents are the focus of approximately 65
national health objectives in Healthy People 2030, an initiative of the
U.S. Department of Health and Human Services (HHS). The YRBS provides
data to measure 13 of the proposed health objectives and one of the
Leading Health Indicators currently under public comment to establish
Healthy People 2030 objectives. In addition, the YRBS can identify
racial and ethnic disparities in health risk behaviors. No other
national source of data measures as many of the Healthy People 2030
objectives addressing adolescent health risk behaviors as the YRBS. The
data also will have significant implications for policy and program
development for school health programs nationwide.
In Spring 2021 and Spring 2023, the YRBS will be conducted among
nationally representative samples of students attending public and
private schools in grades 9-12. Information supporting the YRBS also
will be collected from state-, district-, and school-level
administrators and teachers. The table below reports the number of
respondents annualized over the three-year project period. There are no
costs to respondents except their time. The total estimated annualized
burden hours are 6,259.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response Total burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
State Administrators.......... State-level 17 1 30/60 9
Recruitment
Script for the
Youth Risk
Behavior Survey.
District Administrators....... District-level 80 1 30/60 40
Recruitment
Script for the
Youth Risk
Behavior Survey.
School Administrators......... District-level 133 1 30/60 67
Recruitment
Script for the
Youth Risk
Behavior Survey.
[[Page 11995]]
Teachers...................... Data Collection 440 1 15/60 110
Checklist for
the Youth Risk
Behavior Survey.
Students...................... Youth Risk 8,045 1 45/60 6,034
Behavior Survey.
---------------------------------------------------------------------------------
Total..................... ................ .............. .............. .............. 6,259
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-04084 Filed 2-27-20; 8:45 am]
BILLING CODE 4163-18-P
